The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
As hospitals restructure to gain sustainability in an era of reform, it is crucial for supply chain leaders to work collaboratively within health…
On-Demand Educational Webinars
Reducing variability in products, supplies, pharmaceuticals, and other cost drivers is key to achieving margins in Medicare payment. This webinar…
On-Demand Educational Webinars
Social responsibility is an emerging area of importance for all health care supply chain professionals to understand and participate in. This webinar…
On-Demand Educational Webinars
Cybersecurity impacts all industry verticals including health care. Health care organizations need to address security in standard technology and…
Podcasts
John Kelty from W.L.
On-Demand Educational Webinars
Today, health systems are being forced to leverage disparate data from internal and external sources to drive business intelligence solutions. In…